What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes
Open Access
- 4 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 925427
Abstract
MHC class I antigen E (HLA-E), a ligand for the inhibitory NKG2A/CD94 receptor of the immune system, is responsible for evading the immune surveillance in several settings, including senescent cell accumulation and tumor persistence. The formation of this ligand-receptor interaction promotes the inhibition of the cytolytic action of immune system natural killer (NK) cells and CD8+T-cells expressing this receptor. The final outcome of the HLA-E/NKG2A/CD94 interaction on target cells is also highly dependent on the identity of the nonameric peptide incorporated into the HLA-E ligand. To better understand the role played by a nonameric peptide in these immune complexes, we performed a series of multi-microsecond all-atom molecular dynamics simulations. We generated natural and alternative variants of the nonameric peptide bound to the HLA-E ligand alone or in the HLA-E/NKG2A/CD94 complexes. A systematic study of molecular recognition between HLA-E and peptides led to the development of new variants that differ at the strategic 6th position (P6) of the peptide and have favorablein silicoproperties comparable to those of natural binding peptides. Further examination of a selected subset of peptides in full complexes revealed a new variant that, according to our previously derived atomistic model, can interfere with the signal transductionviaHLA-E/NKG2A/CD94 and thus prevent the target cell from evading immune clearance by NK and CD8+T-cells. These simulations provide an atomistic picture of how a small change in amino acid sequence can lead to a profound effect on binding and molecular recognition. Furthermore, our study also provides new data on the peptide interaction motifs as well as the energetic and conformational properties of the binding interface, laying the structure-based foundation for future development of potential therapeutic peptides, peptidomimetics, or even small molecules that would bind to the HLA-E ligand and abrogate NKG2A/CD94 recognition. Such external intervention would be useful in the emerging field of targeting senescent cells in a variety of age-related diseases, as well as in novel cancer immunotherapies.Keywords
Funding Information
- The Slovenian Research and Innovation Agency (P1-0017 P1-0012 J1-3019 39011)
This publication has 69 references indexed in Scilit:
- Desolvation Costs of Salt Bridges across Protein Binding Interfaces: Similarities and Differences between Implicit and Explicit Solvent ModelsThe Journal of Physical Chemistry Letters, 2010
- Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94–NKG2 Natural Killer Cell ReceptorsJournal of Molecular Biology, 2008
- CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequenceJournal of Experimental Medicine, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculationsNucleic Acids Research, 2004
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Langevin dynamics of peptides: The frictional dependence of isomerization rates of N‐acetylalanyl‐N′‐methylamideBiopolymers, 1992
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984
- Correlation of sequence hydrophobicities measures similarity in three-dimensional protein structureJournal of Molecular Biology, 1983
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983